ArticleLife (Basel, Switzerland)2026
Association of Coronary Artery Calcium Score with Cardiovascular Outcomes in Patients Without Known Coronary Artery Disease.
Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elevated coronary artery calcium (CAC) is associated with increased cardiovascular and all-cause mortality. Coronary artery calcium score (CACS) may aid cardiovascular risk assessment beyond traditional models, particularly in primary prevention populations. This study aimed to evaluate the association between CACS and major adverse cardiovascular events (MACE) and its relationship with conventional cardiovascular risk models in patients without established coronary artery disease. We conducted a retrospective analysis of patients aged >40 years with at least one cardiovascular risk factor who underwent computed tomography coronary angiography. Data on cardiovascular risk factors, medication use, atherosclerotic cardiovascular disease (ASCVD) score, MESA score, and CACS were collected. Among 100 patients (61% male; mean age 57.1 ± 10.7 years), 47% were at intermediate ASCVD risk. Median CACS was 65.0 (IQR 0.0-383.3). CACS was significantly associated with ASCVD and MESA scores. In multivariable analysis, glucose level, ASCVD score, and MESA score were significantly associated with MACE, while CACS showed a borderline association. These findings should be interpreted as exploratory and suggest that CACS reflects overall cardiovascular risk burden and may contribute to risk assessment when integrated with conventional approaches. Further prospective studies are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.